From: Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study
Characteristics
Data
ORR (%)
25.00 (95%CI: 10.7-44.9)
DCR (%)
50.00 (95%CI: 30.6-69.4)
M-PFS (months)
2.25(95%CI: 1.80-3.00)
4 months PFS rate (%)
17.9 (95%CI: 0.081-0.395)
6 months PFS rate (%)
7.1 (95%CI: 0.019-0.272)